Precigen | 8-K: Current report
Mar 19 16:22 ET
Precigen | 8-K: Current report
Feb 8 16:27 ET
Precigen | 8-K: Current report
Jan 8 00:00 ET
Precigen | S-3: Registration statement for specified transactions by certain issuers
Dec 29, 2023 00:00 ET
Precigen | 8-K: Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs
Nov 9, 2023 17:07 ET
Precigen | 8-K: Precigen Reports Second Quarter and First Half 2023 Financial Results and Provides Update on Portfolio Prioritization and Capital Allocation Strategies to Extend Projected Cash Runway into 2025
Aug 9, 2023 08:15 ET
Precigen | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Jul 6, 2023 17:09 ET
Precigen | 8-K: Current report
Jun 9, 2023 16:32 ET
Precigen | 8-K: Precigen Reports First Quarter 2023 Financial Results and Business Updates
May 10, 2023 08:00 ET
Precigen | DEFA14A: Others
Apr 25, 2023 16:15 ET
Precigen | DEF 14A: Definitive proxy statements
Apr 25, 2023 16:06 ET
Precigen | 8-K: Current report
Apr 4, 2023 21:16 ET
Precigen | 8-K: Current report
Mar 13, 2023 06:06 ET
Precigen | 8-K: Precigen Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
Mar 6, 2023 16:13 ET
Precigen | 8-K: Current report
Jan 27, 2023 08:31 ET
Precigen | 8-K: Current report
Jan 24, 2023 16:10 ET
Precigen | 8-K: Current report
Jan 11, 2023 19:01 ET
Precigen | 8-K: Precigen Reports Third Quarter 2022 Financial Results and Progress of Clinical Programs
Nov 9, 2022 16:14 ET
Precigen: Current report
8-K | PRECIGEN, INC. (0001356090) (Filer)
Sep 21, 2022 17:07 ET
Precigen | 8-K/A: Current report (Amendment)
Aug 24, 2022 16:28 ET
No Data
No Data